Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS
Editor’s Choice Brain atrophy outcomes of 590 patients were analyzed by the percentage brain volume change measured by structural image evaluation with normalization of atrophy on 2D-T1WI and 3D-T1WI and the percentage lateral ventricle volume change, measured by VIENA on